# To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants

> **NCT07490587** · PHASE2 · RECRUITING · sponsor: **Min-Tze LIONG** · enrollment: 366 (estimated)

## Conditions studied

- Healthy Children

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07490587
- **Lead sponsor:** Min-Tze LIONG
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07490587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07490587, "To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07490587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*